Navitas Life Sciences

Euglycemic Clamp Studies

According to an ICMR study published in lancet in 2023, it is estimated that over 100 million people in India have diabetes. 4.3 million people in the UK are estimated to be living with Diabetes, while the Centers for Disease Control and Prevention (CDC) states that more than 37 million people in the US have diabetes. It is important, therefore, to find suitable therapy that will aid in better management and control of diabetes.

Navitas Life Sciences has the capabilities and resources to enable biosimilars companies to bring effective anti-diabetic therapies to the market quickly and safely.


Please complete form to download PDF
First Name
Last Name
Business Email
Job Title
By submitting this form, I agree to receive email communications from Navitas Life Sciences. Privacy Policy

© 2023 Navitas Life Sciences | Privacy Policy